Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
transcranial magnetic stimulation
MedTech
Neuronetics TMS nets first-line OK for depression in adolescents
The drug-free approach uses magnetic coils to generate pulses that aim to restart dormant synapse pathways in brain regions that help govern mood.
Conor Hale
Mar 26, 2024 11:02am
Neuronetics gets FDA clearance for NeuroStar add-on in OCD
Jun 14, 2023 5:00pm
Magnus Medical debuts with $25M to target severe depression
Oct 29, 2021 11:10am
FDA OKs BrainsWay’s neurostim device to ease anxious depression
Aug 18, 2021 9:49am
Neuronetics CEO Thatcher to step down
Mar 9, 2020 10:01am
BrainsWay shows early success treating ADHD with strong magnets
Feb 20, 2020 10:21am
